Full Professor of Haematology, Head of Chair of Haematology, and Director of Unit Blood Diseases and Bone Marrow Transplantation at Department of Clinical and Experimental Sciences, University of Brescia; Department of Oncology, ASST-Spedali Civili of Brescia, Italy
Prof. Dr. Domenico Russo is a distinguished haematologist currently serving as a Full Professor and Head of the Chair of Haematology in the Department of Clinical and Experimental Sciences at the University of Brescia. He also holds the position of Director of the Blood Diseases and Bone Marrow Transplantation Unit at ASST-Spedali Civili of Brescia. With an M.D. from the University of Bologna and extensive training in haematology, Dr. Russo has contributed significantly to the field, authoring over 500 peer-reviewed scientific articles. His research focuses on chronic myeloid leukaemia, acute leukaemias, and CAR-T cell therapy, among other areas. A prominent figure in academia and clinical practice, he has played vital roles in various research councils and has coordinated numerous PhD programs. His leadership and innovative research have earned him recognition as a leading expert in haematology and oncology.
Profile:
Education
Prof. Dr. Domenico Russo obtained his Medical Degree (M.D.) from the University of Bologna in 1982. He completed his Residency Training in Haematology in 1985, followed by postdoctoral research at the Institute of Haematology “L. e A. Seràgnoli” at Bologna University in 1989. His commitment to advancing his expertise in the field led him to pursue further research as a Research Fellow at the Laboratory of Cellular Kinetics at the Hotel Dieu Hospital in Paris from 1991 to 1993. These educational experiences have provided him with a robust foundation in haematology and clinical research, enabling him to excel in his academic and professional endeavors.
Professional Experiences
Prof. Dr. Domenico Russo has a rich and varied professional background in haematology and oncology. Currently, he serves as a Full Professor and Head of the Chair of Haematology at the University of Brescia, where he has been a faculty member since 2001. He also leads the Blood Diseases and Bone Marrow Transplantation Unit at ASST-Spedali Civili of Brescia, a role he has held since 2004. His previous positions include Assistant Professor at the University of Udine and Associate Professor at the University of Brescia. Additionally, Dr. Russo has served as Director of the Fellowship School of Haematology from 2004 to 2023 and has been instrumental in the coordination of the PhD in Artificial Intelligence in Medicine and Innovation in Clinical Research and Methodology since 2020. He has also been actively involved in various research councils, including the Italian Cooperative Study Group on Chronic Myeloid Leukaemia. Over the years, he has directed numerous clinical trials and research projects, significantly impacting the understanding and treatment of haematological diseases.
Research Interests
Prof. Dr. Domenico Russo’s research interests are primarily focused on haematology, particularly in the areas of chronic myeloid leukaemia and acute leukaemias. His work extensively explores the mechanisms of multidrug resistance and the development of novel antitumor drugs. He is also deeply involved in translational molecular biology and genomics, aiming to enhance the understanding of acute and chronic leukaemias. Additionally, Dr. Russo is interested in the advancements of CAR-T cell therapy and regenerative medicine, with a keen focus on improving patient outcomes through innovative therapies. With over 30 years of experience, he has been the principal investigator in numerous national and international research projects, contributing significantly to the field of onco-haematological diseases and advancing therapeutic strategies for patients.
Research skills
Prof. Dr. Domenico Russo possesses a diverse and robust skill set that enhances his contributions to haematology and oncology research. His expertise includes advanced methodologies in cellular kinetics and molecular biology, enabling him to investigate the mechanisms underlying leukaemia and treatment resistance. Dr. Russo is skilled in designing and conducting clinical trials, having led over 60 trials in the past decade, which reflects his proficiency in translating research findings into clinical applications. Additionally, he is adept at coordinating multi-disciplinary research teams, managing budgets, and overseeing complex projects in national and international contexts. His strong analytical skills are complemented by his ability to effectively communicate research findings through numerous peer-reviewed publications and conference presentations, making him a pivotal figure in advancing the field of haematological research.
Award And Recoginition
Prof. Dr. Domenico Russo has received numerous accolades throughout his distinguished career in haematology and oncology. His contributions to the field have been recognized through various awards, reflecting his commitment to advancing cancer research and patient care. Notably, he has been honored for his leadership in the Italian Society of Experimental Haematology, serving as General Secretary and Advisor, which highlights his influence in shaping research agendas and promoting collaboration among scientists. His significant bibliometric achievements, including over 500 peer-reviewed publications and an impressive H-Index, underscore his impact on the scientific community. Furthermore, Dr. Russo’s leadership in clinical trials and research projects funded by national and international bodies showcases his role in pioneering innovative therapies for haematological diseases. His recognition extends to invitations as a speaker and contributor at major conferences, where he shares his expertise and insights with peers, further solidifying his status as a leading researcher in the field.
Conclusion
- Busulfan-fludarabine versus busulfan-cyclophosphamide for allogeneic transplant in acute myeloid leukemia: long-term analysis of GITMO AML-R2 trial
- Authors: Cavallaro, G., Grassi, A., Pavoni, C., Bacigalupo, A., Rambaldi, A.
- Year: 2024
- Citations: 0
- A Multicenter Real-life Prospective Study of Axicabtagene Ciloleucel versus Tisagenlecleucel Toxicity and Outcomes in Large B-cell Lymphomas
- Authors: Stella, F., Chiappella, A., Casadei, B., Miceli, R., Corradini, P.
- Year: 2024
- Citations: 0
- In Vitro Biocompatibility Assessment of Bioengineered PLA-Hydrogel Core–Shell Scaffolds with Mesenchymal Stromal Cells for Bone Regeneration
- Authors: Re, F., Sartore, L., Pasini, C., Farina, M., Russo, D.
- Year: 2024
- Citations: 0
- BCR::ABL1 digital PCR for treatment-free remission prediction in chronic myeloid leukemia patients: An individual participant data meta-analysis
- Authors: Kockerols, C., Valk, P.J.M., Dulucq, S., Cornelissen, J.J., Westerweel, P.E.
- Year: 2024
- Citations: 0
- Gelatin-Based Scaffolds with Carrageenan and Chitosan for Soft Tissue Regeneration
- Authors: Pasini, C., Re, F., Trenta, F., Russo, D., Sartore, L.
- Year: 2024
- Citations: 0
- Evaluation of Circulating Endothelial Cells as Direct Marker of Endothelial Damage in Allo-Transplant Recipients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome
- Authors: Farina, M., Scaini, M.C., Facchinetti, A., Poggiana, C., Russo, D.
- Year: 2024
- Citations: 0
- Nutritional Strategies To Improve VRE Control
- Authors: Morello, E., Roversi, S., Brambilla, G., Caruso, A., Russo, D.
- Year: 2024
- Citations: 0
- Impact of comorbidities and body mass index on the outcomes of allogeneic hematopoietic cell transplantation in myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of EBMT
- Authors: Polverelli, N., Bonneville, E.F., de Wreede, L.C., Hernández-Boluda, J.C., McLornan, D.P.
- Year: 2024
- Citations: 4